The Risk of Hepatitis B and Tuberculosis Reactivation in Patients with Neuromyelitis Optica Spectrum Disorder Treated with B-Cell Depletion Therapy (P7-8.010)
This study aims to evaluate the risk of hepatitis B or tuberculosis reactivation in neuromyelitis optica spectrum disorder (NMOSD) patients with potential occult hepatitis B virus (HBV) infection (pOBI) or latent tuberculosis infection (LTBI) undergoing B-cell depletion therapy, providing evidence for clinical decision-making.
Authors
- Shengfei Hu
- Rui Li (ORCID: https://orcid.org/0000-0002-0468-8848)
- Xi Wang (ORCID: https://orcid.org/0000-0002-6065-7130)
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210457
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00